# Lamotrigine Extended-Release In Elderly Patients With Epilepsy

> **NCT00516139** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 122 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT00516139
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516139, "Lamotrigine Extended-Release In Elderly Patients With Epilepsy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00516139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*